Ultrastructural features of neuroblastic tumours in relation to morphological, and molecular findings; A retrospective review study

BMC Clinical Pathology

Volumn 14, Issue 1, 2014, Pages

  Latimer, Elizabeth ^b   Anderson, Glenn ^b   Sebire, Neil James ^a,b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Electron microscopy; Molecular biology; MYCN; Neuroblastoma; Ultrastructure

Indexed keywords

MYC PROTEIN;

ARTICLE; CELL ULTRASTRUCTURE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MEDICAL RECORD REVIEW; MICROTUBULE; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA; NEUROSECRETORY CELL; RETROSPECTIVE STUDY;

EID: 84900333831     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-14-13     Document Type: Article

References (23)

1. Neuroblastoma: biology and molecular and chromosomal pathology. Schwab M, Westermann F, Hero B, Berthold F, Lancet Oncol 2003 4 472 480 10.1016/S1470-2045(03)01166-5 12901961
2. Neuroblastoma: biology, prognosis, and treatment. Park JR, Eggert A, Caron H, Hematol/Oncol Clin N Am 2010 24 65 86 10.1016/j.hoc.2009.11.011
3. Advances in the diagnosis and treatment of neuroblastoma. Weinstein JL, Katzenstein HM, Cohn SL, Oncologist 2003 8 278 292 10.1634/theoncologist.8-3-278 12773750
4. Tumours. Chapter 6. Sebire NJ, Malone M, Ashworth M, Jacques TS, Diagnostic Pediatric Surgical Pathology London: Churchill Livingstone 2010 165 172
5. Neuroblastoma: biology and staging. Mueller S, Matthay KK, Curr Oncol Rep 2009 11 431 438 10.1007/s11912-009-0059-6 19840520
6. The MYCN oncogene and differentiation in neuroblastoma. Westermark UK, Wilhelm M, Frenzel A, Henriksson MA, Semin Canc Biol 2011 21 256 266 10.1016/j.semcancer.2011.08.001
7. Differential expression of myc family genes during murine development. Zimmerman KA, Yancopoulos GD, Collum RG, Smith RK, Kohl NE, Denis KA, Nau MM, Witte ON, Toran-Allerand D, Gee CE, Minna JD, Alt FW, Nature 1986 319 780 783 10.1038/319780a0 2419762
8. The MYCN enigma: significance of MYCN expression in neuroblastoma. Tang XX, Zhao H, Kung B, Kim DY, Hicks SL, Cohn SL, Cheung NK, Seeger RC, Evans AE, Ikegaki N, Canc Res 2006 66 2826 2833 10.1158/0008-5472.CAN-05-0854
9. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1. Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Fukuba I, Matsuura Y, Yokoyama T, Med Pediat Oncol 2001 6 67 74
10. Electron microscopic study of neuroblastoma. Yanagisawa M, Paediatr Univ Tokyo 1970 17 29 39 4315851
11. Ultrastructural studies on neuroblastoma: evaluation of cytodifferentiation and correlation of morphology and biochemical and survival data. Romansky SG, Crocker DW, Shaw KN, Cancer 1978 42 2392 2398 10.1002/1097-0142(197811)42:5<2392::AID-CNCR2820420540>3.0.CO;2-C 719615
12. Electron microscopy in the diagnosis of neuroblastoma. Taxy JB, Arch Pathol Lab Med 1980 104 355 360 6893122
13. Transmission and scanning electron microscopic studies on the tumors of neuroblastoma group. Shimada H, Acta Pathol Jpn 1982 32 415 426 6285664
14. Comparison of ultrastructural features among neuroblastic tumors: maturation from neuroblastoma to ganglioneuroma. Hicks MJ, Mackay B, Ultrastruct Pathol 1995 19 311 322 10.3109/01913129509064236 7571090
15. Theory and Practice of Histological Techniques. Bancroft JD, Gamble M, London: Churchill Livingstone Sixth 2008 126 127
16. Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma. United Kingdom Children's Cancer Study Group. Taylor CP, Bown NP, McGuckin AG, Lunec J, Malcolm AJ, Pearson AD, Sheer D, Br J Canc 2000 83 40 49
17. Binomial mitotic segregation of MYCN-carrying double minutes in neuroblastoma illustrates the role of randomness in oncogene amplification. Lundberg G, Rosengren AH, Håkanson U, Stewénius H, Jin Y, Stewénius Y, Påhlman S, Gisselsson D, PLoS One 2008 3 3099 10.1371/journal.pone.0003099 18769732
18. Diagnostic Transmission electron Microscopy of Tumors. Erlandson RA, New York: Raven Press 1994 555 562
19. MYC's broad reach. Eilers M, Eisenman RN, Genes Dev 2008 22 2755 2766 10.1101/gad.1712408 18923074
20. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF, Genes Dev 1992 6 2235 2247 10.1101/gad.6.12a.2235 1459449
21. Regulation of the neural crest cell fate by N-myc: promotion of ventral migration and neuronal differentiation. Wakamatsu Y, Watanabe Y, Nakamura H, Kondoh H, Development 1997 197 124 1953 1962
22. MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development. Alam G, Cui H, Shi H, Yang L, Ding J, Mao L, Maltese WA, Ding HF, Am J Pathol 2009 175 856 866 10.2353/ajpath.2009.090019 19608868
23. Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma. Gustafson WC, Matthay KK, Exp Rev Neurotherapeutics 2011 11 1411 1423 10.1586/ern.11.103